From “Nasdaq”: 2024-07-26 11:45:17

Centene Corporation announced its second quarter financial results in a conference call hosted by CEO Sarah London and CFO Drew Asher. They reported adjusted diluted EPS of $2.42, exceeding expectations. The company saw pressure in Medicaid due to redeterminations, but remains optimistic about returning to pre-pandemic performance. Centene’s marketplace business, Ambetter Health, continues to excel and is contributing to margin expansion. The company is focusing on operational improvements and innovations like the HALO program for substance use disorder recovery. Centene also highlighted recent contract wins in critical states like Florida and Kansas, positioning the company for long-term growth in the Medicaid market.



Read more at “Nasdaq”: Centene (CNC) Q2 2024 Earnings Call Transcript